Quantifying Intranasal Nose to Brain Cell Secretome Delivery to Non-Human Primates and Clinical Translation From Preclinical to Clinical Settings

Time: 9:30 am
day: Day 2

Details:

  • Quantifying labeled protein techniques to measure drug distribution with biomarker analyses and exploring the therapeutic effect of intranasal delivery in human subjects
  • Discussion of the critical regulatory pathways and methodologies that bridge preclinical findings to clinical applications
  • Clinical case study presentation demonstrating targeted intranasal nose to brain delivery, highlighting key results, challenges faced, and lessons learned

Speakers: